Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).
Identifieur interne : 000F48 ( Main/Exploration ); précédent : 000F47; suivant : 000F49Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).
Auteurs : Abraham Palache [Pays-Bas] ; Valerie Oriol-Mathieu [Pays-Bas] ; Atika Abelin [France] ; Tamara Music [Suisse]Source :
- Vaccine [ 1873-2518 ] ; 2014.
Descripteurs français
- KwdFr :
- Disparités d'accès aux soins (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Programmes de vaccination (statistiques et données numériques), Santé mondiale (MeSH), Santé publique (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (ressources et distribution).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- ressources et distribution : Vaccins antigrippaux.
- statistiques et données numériques : Programmes de vaccination, Vaccination.
- Disparités d'accès aux soins, Humains, Santé mondiale, Santé publique.
English descriptors
- KwdEn :
- Global Health (MeSH), Healthcare Disparities (MeSH), Humans (MeSH), Immunization Programs (statistics & numerical data), Influenza Vaccines (administration & dosage), Influenza Vaccines (supply & distribution), Influenza, Human (prevention & control), Public Health (MeSH), Vaccination (statistics & numerical data).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- prevention & control : Influenza, Human.
- statistics & numerical data : Immunization Programs, Vaccination.
- chemical , supply & distribution : Influenza Vaccines.
- Global Health, Healthcare Disparities, Humans, Public Health.
Abstract
Globally there are an estimated 3-5 million cases of severe influenza illness every year, resulting in 250,000-500,000 deaths. At the World Health Assembly in 2003, World Health Organization (WHO) resolved to increase influenza vaccine coverage rates (VCR) for high-risk groups, particularly focusing on at least 75% of the elderly by 2010. But systematic worldwide data have not been available to assist public health authorities to monitor vaccine uptake and review progress toward vaccination coverage targets. In 2008, the International Federation of Pharmaceutical Manufacturers and Associations Influenza Vaccine Supply task force (IFPMA IVS) developed a survey methodology to assess global influenza vaccine dose distribution. The current survey results represent 2011 data and demonstrate the evolution of the absolute number distributed between 2004 and 2011 inclusive, and the evolution in the per capita doses distributed in 2008-2011. Global distribution of IFPMA IVS member doses increased approximately 86.9% between 2004 and 2011, but only approximately 12.1% between 2008 and 2011. The WHO's regions in Eastern Mediterranean (EMRO), Southeast Asian (SEARO) and Africa (AFRO) together account for about 47% of the global population, but only 3.7% of all IFPMA IVS doses distributed. While distributed doses have globally increased, they have decreased in EURO and EMRO since 2009. Dose distribution can provide a reasonable proxy of vaccine utilization. Based on the dose distribution, we conclude that seasonal influenza VCR in many countries remains well below the WHA's VCR targets and below the recommendations of the Council of the European Union in EURO. Inter- and intra-regional disparities in dose distribution trends call into question the impact of current vaccine recommendations at achieving coverage targets. Additional policy measures, particularly those that influence patients adherence to vaccination programs, such as reimbursement, healthcare provider knowledge, attitudes, practices, and communications, are required for VCR targets to be met and benefit public health.
DOI: 10.1016/j.vaccine.2014.07.012
PubMed: 25442403
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).</title><author><name sortKey="Palache, Abraham" sort="Palache, Abraham" uniqKey="Palache A" first="Abraham" last="Palache">Abraham Palache</name><affiliation wicri:level="1"><nlm:affiliation>Abbott, C.J. van Houtenlaan 36, 1381 CP, Weesp, The Netherlands. Electronic address: bram.palache@abbott.com.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Abbott, C.J. van Houtenlaan 36, 1381 CP, Weesp</wicri:regionArea><wicri:noRegion>Weesp</wicri:noRegion></affiliation></author><author><name sortKey="Oriol Mathieu, Valerie" sort="Oriol Mathieu, Valerie" uniqKey="Oriol Mathieu V" first="Valerie" last="Oriol-Mathieu">Valerie Oriol-Mathieu</name><affiliation wicri:level="1"><nlm:affiliation>Crucell Holland B.V., Newtonweg 1, 2333 CP, P.O. Box 2048, 2301 Leiden, CA, The Netherlands. Electronic address: VOriolM@its.jnj.com.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Crucell Holland B.V., Newtonweg 1, 2333 CP, P.O. Box 2048, 2301 Leiden, CA</wicri:regionArea><wicri:noRegion>CA</wicri:noRegion></affiliation></author><author><name sortKey="Abelin, Atika" sort="Abelin, Atika" uniqKey="Abelin A" first="Atika" last="Abelin">Atika Abelin</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, 2, Avenue Pont Pasteur, Lyon 69007, France. Electronic address: Atika.Abelin@sanofipasteur.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, 2, Avenue Pont Pasteur, Lyon 69007</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName></affiliation></author><author><name sortKey="Music, Tamara" sort="Music, Tamara" uniqKey="Music T" first="Tamara" last="Music">Tamara Music</name><affiliation wicri:level="1"><nlm:affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. Louis-Dunant 15, P.O. Box 195, 20 1211 Geneva, Switzerland. Electronic address: t.music@ifpma.org.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>International Federation of Pharmaceutical Manufacturers and Associations, Ch. Louis-Dunant 15, P.O. Box 195, 20 1211 Geneva</wicri:regionArea><wicri:noRegion>20 1211 Geneva</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25442403</idno><idno type="pmid">25442403</idno><idno type="doi">10.1016/j.vaccine.2014.07.012</idno><idno type="wicri:Area/Main/Corpus">000E80</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E80</idno><idno type="wicri:Area/Main/Curation">000E80</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000E80</idno><idno type="wicri:Area/Main/Exploration">000E80</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).</title><author><name sortKey="Palache, Abraham" sort="Palache, Abraham" uniqKey="Palache A" first="Abraham" last="Palache">Abraham Palache</name><affiliation wicri:level="1"><nlm:affiliation>Abbott, C.J. van Houtenlaan 36, 1381 CP, Weesp, The Netherlands. Electronic address: bram.palache@abbott.com.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Abbott, C.J. van Houtenlaan 36, 1381 CP, Weesp</wicri:regionArea><wicri:noRegion>Weesp</wicri:noRegion></affiliation></author><author><name sortKey="Oriol Mathieu, Valerie" sort="Oriol Mathieu, Valerie" uniqKey="Oriol Mathieu V" first="Valerie" last="Oriol-Mathieu">Valerie Oriol-Mathieu</name><affiliation wicri:level="1"><nlm:affiliation>Crucell Holland B.V., Newtonweg 1, 2333 CP, P.O. Box 2048, 2301 Leiden, CA, The Netherlands. Electronic address: VOriolM@its.jnj.com.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Crucell Holland B.V., Newtonweg 1, 2333 CP, P.O. Box 2048, 2301 Leiden, CA</wicri:regionArea><wicri:noRegion>CA</wicri:noRegion></affiliation></author><author><name sortKey="Abelin, Atika" sort="Abelin, Atika" uniqKey="Abelin A" first="Atika" last="Abelin">Atika Abelin</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, 2, Avenue Pont Pasteur, Lyon 69007, France. Electronic address: Atika.Abelin@sanofipasteur.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, 2, Avenue Pont Pasteur, Lyon 69007</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName></affiliation></author><author><name sortKey="Music, Tamara" sort="Music, Tamara" uniqKey="Music T" first="Tamara" last="Music">Tamara Music</name><affiliation wicri:level="1"><nlm:affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. Louis-Dunant 15, P.O. Box 195, 20 1211 Geneva, Switzerland. Electronic address: t.music@ifpma.org.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>International Federation of Pharmaceutical Manufacturers and Associations, Ch. Louis-Dunant 15, P.O. Box 195, 20 1211 Geneva</wicri:regionArea><wicri:noRegion>20 1211 Geneva</wicri:noRegion></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Global Health (MeSH)</term><term>Healthcare Disparities (MeSH)</term><term>Humans (MeSH)</term><term>Immunization Programs (statistics & numerical data)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (supply & distribution)</term><term>Influenza, Human (prevention & control)</term><term>Public Health (MeSH)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Disparités d'accès aux soins (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Programmes de vaccination (statistiques et données numériques)</term><term>Santé mondiale (MeSH)</term><term>Santé publique (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (ressources et distribution)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Immunization Programs</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Programmes de vaccination</term><term>Vaccination</term></keywords><keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Global Health</term><term>Healthcare Disparities</term><term>Humans</term><term>Public Health</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Disparités d'accès aux soins</term><term>Humains</term><term>Santé mondiale</term><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Globally there are an estimated 3-5 million cases of severe influenza illness every year, resulting in 250,000-500,000 deaths. At the World Health Assembly in 2003, World Health Organization (WHO) resolved to increase influenza vaccine coverage rates (VCR) for high-risk groups, particularly focusing on at least 75% of the elderly by 2010. But systematic worldwide data have not been available to assist public health authorities to monitor vaccine uptake and review progress toward vaccination coverage targets. In 2008, the International Federation of Pharmaceutical Manufacturers and Associations Influenza Vaccine Supply task force (IFPMA IVS) developed a survey methodology to assess global influenza vaccine dose distribution. The current survey results represent 2011 data and demonstrate the evolution of the absolute number distributed between 2004 and 2011 inclusive, and the evolution in the per capita doses distributed in 2008-2011. Global distribution of IFPMA IVS member doses increased approximately 86.9% between 2004 and 2011, but only approximately 12.1% between 2008 and 2011. The WHO's regions in Eastern Mediterranean (EMRO), Southeast Asian (SEARO) and Africa (AFRO) together account for about 47% of the global population, but only 3.7% of all IFPMA IVS doses distributed. While distributed doses have globally increased, they have decreased in EURO and EMRO since 2009. Dose distribution can provide a reasonable proxy of vaccine utilization. Based on the dose distribution, we conclude that seasonal influenza VCR in many countries remains well below the WHA's VCR targets and below the recommendations of the Council of the European Union in EURO. Inter- and intra-regional disparities in dose distribution trends call into question the impact of current vaccine recommendations at achieving coverage targets. Additional policy measures, particularly those that influence patients adherence to vaccination programs, such as reimbursement, healthcare provider knowledge, attitudes, practices, and communications, are required for VCR targets to be met and benefit public health. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25442403</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>48</Issue><PubDate><Year>2014</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).</ArticleTitle><Pagination><MedlinePgn>6369-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2014.07.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(14)00938-4</ELocationID><Abstract><AbstractText>Globally there are an estimated 3-5 million cases of severe influenza illness every year, resulting in 250,000-500,000 deaths. At the World Health Assembly in 2003, World Health Organization (WHO) resolved to increase influenza vaccine coverage rates (VCR) for high-risk groups, particularly focusing on at least 75% of the elderly by 2010. But systematic worldwide data have not been available to assist public health authorities to monitor vaccine uptake and review progress toward vaccination coverage targets. In 2008, the International Federation of Pharmaceutical Manufacturers and Associations Influenza Vaccine Supply task force (IFPMA IVS) developed a survey methodology to assess global influenza vaccine dose distribution. The current survey results represent 2011 data and demonstrate the evolution of the absolute number distributed between 2004 and 2011 inclusive, and the evolution in the per capita doses distributed in 2008-2011. Global distribution of IFPMA IVS member doses increased approximately 86.9% between 2004 and 2011, but only approximately 12.1% between 2008 and 2011. The WHO's regions in Eastern Mediterranean (EMRO), Southeast Asian (SEARO) and Africa (AFRO) together account for about 47% of the global population, but only 3.7% of all IFPMA IVS doses distributed. While distributed doses have globally increased, they have decreased in EURO and EMRO since 2009. Dose distribution can provide a reasonable proxy of vaccine utilization. Based on the dose distribution, we conclude that seasonal influenza VCR in many countries remains well below the WHA's VCR targets and below the recommendations of the Council of the European Union in EURO. Inter- and intra-regional disparities in dose distribution trends call into question the impact of current vaccine recommendations at achieving coverage targets. Additional policy measures, particularly those that influence patients adherence to vaccination programs, such as reimbursement, healthcare provider knowledge, attitudes, practices, and communications, are required for VCR targets to be met and benefit public health. </AbstractText><CopyrightInformation>Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palache</LastName><ForeName>Abraham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Abbott, C.J. van Houtenlaan 36, 1381 CP, Weesp, The Netherlands. Electronic address: bram.palache@abbott.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriol-Mathieu</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Crucell Holland B.V., Newtonweg 1, 2333 CP, P.O. Box 2048, 2301 Leiden, CA, The Netherlands. Electronic address: VOriolM@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abelin</LastName><ForeName>Atika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sanofi Pasteur, 2, Avenue Pont Pasteur, Lyon 69007, France. Electronic address: Atika.Abelin@sanofipasteur.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Music</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. Louis-Dunant 15, P.O. Box 195, 20 1211 Geneva, Switzerland. Electronic address: t.music@ifpma.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Influenza Vaccine Supply task force (IFPMA IVS)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Vaccine. 2014 Dec 12;32(52):7037-9</RefSource><PMID Version="1">25444824</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Monitoring and evaluation</Keyword><Keyword MajorTopicYN="N">Seasonal influenza</Keyword><Keyword MajorTopicYN="N">Vaccination coverage rates</Keyword><Keyword MajorTopicYN="N">Vaccination policy</Keyword><Keyword MajorTopicYN="N">Vaccine recommendations</Keyword><Keyword MajorTopicYN="N">Vaccine reimbursement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25442403</ArticleId><ArticleId IdType="pii">S0264-410X(14)00938-4</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2014.07.012</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Pays-Bas</li><li>Suisse</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Rhône-Alpes</li></region></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Palache, Abraham" sort="Palache, Abraham" uniqKey="Palache A" first="Abraham" last="Palache">Abraham Palache</name></noRegion><name sortKey="Oriol Mathieu, Valerie" sort="Oriol Mathieu, Valerie" uniqKey="Oriol Mathieu V" first="Valerie" last="Oriol-Mathieu">Valerie Oriol-Mathieu</name></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Abelin, Atika" sort="Abelin, Atika" uniqKey="Abelin A" first="Atika" last="Abelin">Atika Abelin</name></region></country><country name="Suisse"><noRegion><name sortKey="Music, Tamara" sort="Music, Tamara" uniqKey="Music T" first="Tamara" last="Music">Tamara Music</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F48 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F48 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SanteMusiqueV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25442403
|texte= Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25442403" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SanteMusiqueV1
| This area was generated with Dilib version V0.6.38. |  |